Stock Events

Stock Events

Tonix Pharmaceuticals (TNXP) Q2 2026 Earnings

11MayConfirmed

Q3 2025

Q4 2025

Q1 2026

Q2 2026

-3.98

-3.51

-3.04

-2.57

Details

Expected EPS

-2.57

Actual EPS

-2.93

Surprise EPS

-0.36

Surprise Percent

+14.01%

Description

Tonix Pharmaceuticals (TNXP) has reported earnings of -2.93 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.